Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
primary studies published RCT
Details- 2010
- Tramper-Stranders GA
Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation.
primary studies published RCT
Details- 2010
- West K
Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
primary studies published RCT
Details- 2009
- Chapman I
A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis.
primary studies published RCT
Details- 2009
- Dauletbaev N
Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical status.
primary studies published RCT
Details- 2009
- Dogru D
Pulmonary delivery of tobramycin by an investigational EFlow electronic nebulizer saves 50% of the drug, and results in equivalent or improved tobramycin safety levels in plasma and sputum [abstract].
primary studies published RCT
Details- 2009
- Griese M
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.
primary studies published RCT
Details- 2009
- Hubert D
Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.
primary studies published RCT
Details- 2009
- Hubert D
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis.
primary studies published RCT
Details- 2009
- Jacquemin E
Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
primary studies published RCT
Details- 2009
- Khazai NB